Cancer drug sales could hit $80 billion by 2011: IMS (Reuters) Posted on May 16th
Expensive new treatments, an increasing number of patients
on chemotherapy in major markets and evidence that more people
in emerging markets are gaining access to modern targeted
therapies will contribute to sales of cancer drugs growing at a
compound rate of 12 to 15 percent, IMS said.
Trackback URL